BioCryst Pharmaceuticals, Inc.
BCRX
Jodie situation report
BioCryst Pharmaceuticals, Inc.'s current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 6 directly disclosed connections are confirming.
- Revenue increased 33.6% versus the comparable filing period.
- Reported $25.6M increase in ORLADEYO revenue (ex-Europe) attributed to increased direct sales and a net price increase; track future revenue and stated demand/price drivers.
Invalidation: The isolated read changes if BCRX's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind BCRX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
CLSDQFiling-linked namepartnerFeb 26, 2026 ▾
“Avoralstat We are developing our investigational plasma kallikrein inhibitor, avoralstat, with Clearside Biomedical, Inc.’s SCS Microinjector ® to deliver avoralstat to the back of the eye through the suprachoroidal space to treat patients with diabetic macul…”
SGIOFFiling-linked namepartnerFeb 26, 2026 ▾
“In January 2010, our partner, Shionogi, received the first approval for peramivir injection and launched it in Japan under the commercial name RAPIACTA.”
NBRGFiling-linked namepartnerFeb 26, 2026 ▾
“In 2021, we entered into supply and distribution agreements with Neopharm Ltd.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
BCRX is currently a Leader in the organic co-movement group Hereditary Angioedema Drugs. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for BCRX; it is not active in the latest market snapshot.